Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,562.79
(
-0.74%
)
US TECH 100
23,286.00
(
-1.08%
)
Dow Jones
46,314.86
(
-0.76%
)
Brent Oil
106.87
(
-0.19%
)
Bitcoin
68,423.23
(
-0.63%
)
News Focus
News Focus
Post# of 405171
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

MinnieM

Send PM Follow Ignore
Followers 616
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

MinnieM

Re: scottsmith post# 203856

Thursday, 11/16/2017 12:58:36 PM

Thursday, November 16, 2017 12:58:36 PM

Post# of 405171
Regarding Brilacidin ph2b ABSSSI. The company told several of us at the 2015 Biotech Showcase that they don't want to partner with anyone until Brilacidin is in or done with phase III. They feel they'll get a substantially better deal at that time.




In Reply to 'scottsmith'
Agree. I’ve been saying, literally for years, that Leo should license by indication. I must say I received some blowback. But then here is the question — why the heck hasn’t our Uncle Leo licensed absssi??


To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote